Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia-Reference-Cited by-同舟云学术

Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia

Published:1995-10 Issue:4 Volume:99 Page:362-369
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Raskin Philip,Ganda Om P.,Schwartz Sherwyn,Willard David,Rosenstock Julio,Lodewick Peter A.,Cressman Michael D.,Phillipson Beverly,Weiner Bonnie,McGovern Mark E.,Norton Jean M.,Cucinotta Gabriella G.,Behounek Bruce D.

Publisher

Elsevier BV

Subject

General Medicine

Reference44 articles.

1. Atherogenesis in diabetes;Bierman;Arter Thromb.,1992

2. Diabetes and heart disease;Barrett-Connor,1985

3. Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study;Garcia;Diabetes,1974

4. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham Study;Kannel;Diabetes Care.,1979

5. Lipids, diabetes, and coronary heart disease: insights from the Framingham Study;Kannel;Am Heart J.,1985

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pasolini, the Notes, 'La Liberta': an Unknown Article and Journalism in Rome in the Early 1950s;STUDI PASOLINIANI;2023

2. Antidiabetic Activity (Anti-Hyperglycemic Activity, Anti-Hyperlipidemic Activity)/Agents From Medicinal Plants;Research Anthology on Recent Advancements in Ethnopharmacology and Nutraceuticals;2022

3. Antidiabetic Activity (Anti-Hyperglycemic Activity, Anti-Hyperlipidemic Activity)/Agents From Medicinal Plants;Advanced Pharmacological Uses of Medicinal Plants and Natural Products;2020

4. Statin Adverse Effects;American Journal of Cardiovascular Drugs;2008

5. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial;Hepatology;2007-08-01